Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring associations between area deprivation index, income, and loneliness among cancer caregivers.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Examining Social Support and Digital Literacy Among Caregivers of People Living With Dementia Receiving Hospice Services.

The American journal of hospice & palliative care·2025
Same author

Defining and Managing End-of-Life Respiratory Changes in Adult Home Hospice Patients: A Systematic Review.

Journal of palliative medicine·2025
Same author

A Mixed-Methods Analysis of Response to NOVELA Among Hospice Family Caregivers.

The American journal of hospice & palliative care·2025
Same author

Defining Family-Centered Cancer Care: A Group Concept Mapping Study.

Psycho-oncology·2025
Same author

Associations between area deprivation and mental health by household income among cancer caregivers.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025

Related Experiment Video

Updated: Jul 1, 2026

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Funding for palliative research: two additional questions

Debra Parker Oliver

    Journal of Palliative Medicine
    |September 16, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
    15:24

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

    Published on: December 16, 2022

    Related Experiment Videos

    Last Updated: Jul 1, 2026

    Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
    06:25

    Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

    Published on: March 29, 2024

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
    15:24

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

    Published on: December 16, 2022